Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
This study evaluates the safety and efficacy of brimonidine 0.2%/timolol 0.5% fixed
combination ophthalmic solution compared with concurrent brimonidine 0.2% and timolol
ophthalmic solutions